Aiba M, Shigematsu A, Suzuki T, Miyagishima T, et al. Shorter duration of venetoclax administration to 14 days has same efficacy and better safety profile in treatment of acute myeloid leukemia. Ann Hematol 2023 Jan 16. doi: 10.1007/s00277-023-05102.
PMID: 36646889